HK1012368A1 - Enantiomers of carbazole derivatives as 5-ht1-likeagonists. - Google Patents

Enantiomers of carbazole derivatives as 5-ht1-likeagonists.

Info

Publication number
HK1012368A1
HK1012368A1 HK98113524A HK98113524A HK1012368A1 HK 1012368 A1 HK1012368 A1 HK 1012368A1 HK 98113524 A HK98113524 A HK 98113524A HK 98113524 A HK98113524 A HK 98113524A HK 1012368 A1 HK1012368 A1 HK 1012368A1
Authority
HK
Hong Kong
Prior art keywords
pct
likeagonists
enantiomers
carbazole derivatives
date jul
Prior art date
Application number
HK98113524A
Other languages
English (en)
Inventor
Gary Thomas Borrett
John Kitteringham
Roderick Alan Porter
Mark Ralph Shipton
Mythily Vimal
Rodney Christopher Young
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Publication of HK1012368A1 publication Critical patent/HK1012368A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK98113524A 1992-12-21 1998-12-15 Enantiomers of carbazole derivatives as 5-ht1-likeagonists. HK1012368A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226530A GB9226530D0 (en) 1992-12-21 1992-12-21 Compounds
PCT/EP1993/003627 WO1994014772A1 (fr) 1992-12-21 1993-12-16 Enantiomeres de derives du carbazole utilises comme agonistes similaires a la 5-ht1

Publications (1)

Publication Number Publication Date
HK1012368A1 true HK1012368A1 (en) 1999-07-30

Family

ID=10726909

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113524A HK1012368A1 (en) 1992-12-21 1998-12-15 Enantiomers of carbazole derivatives as 5-ht1-likeagonists.

Country Status (18)

Country Link
US (2) US5618947A (fr)
EP (1) EP0674621B1 (fr)
JP (1) JP3364222B2 (fr)
KR (1) KR100307001B1 (fr)
CN (1) CN1039491C (fr)
AT (1) ATE233239T1 (fr)
AU (1) AU688748B2 (fr)
CA (1) CA2152630C (fr)
DE (1) DE69332718T2 (fr)
DK (1) DK0674621T3 (fr)
ES (1) ES2193151T3 (fr)
GB (1) GB9226530D0 (fr)
HK (1) HK1012368A1 (fr)
MX (1) MX9400035A (fr)
NZ (1) NZ259363A (fr)
PT (1) PT674621E (fr)
WO (1) WO1994014772A1 (fr)
ZA (1) ZA939457B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
JP2001522884A (ja) * 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
FR2841899A1 (fr) * 2002-07-05 2004-01-09 Ppg Sipsy Procede de resolution asymetrique d'un racemique faisant intervenir l'acide diprogulique et utilisation dudit acide comme agent de resolution asymetrique
WO2006089053A2 (fr) * 2005-02-17 2006-08-24 Wyeth Derive d'indole, benzothiophene, benzofurane et indene a fusion cycloalkyle
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
WO2010073253A1 (fr) * 2008-12-22 2010-07-01 Natco Pharma Limited Procédé de préparation de frovatripan optiquement actif
AU2010240641A1 (en) * 2009-04-23 2011-12-01 Generics [Uk] Limited A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
WO2011095803A1 (fr) * 2010-02-02 2011-08-11 Generics [Uk] Limited Méthode hplc pour l'analyse de frovatriptan
WO2012147020A1 (fr) * 2011-04-25 2012-11-01 Orchid Chemicals And Pharamceuticals Limited Procédé amélioré pour la préparation de frovatriptan
EP2816030A1 (fr) * 2013-06-20 2014-12-24 Duke Chem, S. A. Procédés de préparation de frovatriptan et ses énantiomères
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
CN104402798B (zh) * 2014-10-21 2016-09-14 杭州瑞德化工有限公司 一种3-氨基-1，2，3，4-四氢咔唑的拆分方法
CN104529871A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种琥珀酸呋罗曲坦的制备方法
US11405689B2 (en) * 2020-12-09 2022-08-02 Rovi Guides, Inc. Systems and methods for providing recording of a blacked-out media content item

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
JPS6429699A (en) * 1987-07-24 1989-01-31 Mitsubishi Heavy Ind Ltd Recovery method for adiabatic compression heat
US4874399A (en) * 1988-01-25 1989-10-17 Minnesota Mining And Manufacturing Company Electret filter made of fibers containing polypropylene and poly(4-methyl-1-pentene)
JPH0247924A (ja) * 1988-08-08 1990-02-16 Nec Corp 分周回路
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments

Also Published As

Publication number Publication date
AU688748B2 (en) 1998-03-19
CA2152630A1 (fr) 1994-07-07
GB9226530D0 (en) 1993-02-17
EP0674621B1 (fr) 2003-02-26
PT674621E (pt) 2003-07-31
CN1039491C (zh) 1998-08-12
JPH08504790A (ja) 1996-05-21
EP0674621A1 (fr) 1995-10-04
KR100307001B1 (ko) 2001-12-28
CN1095712A (zh) 1994-11-30
DE69332718T2 (de) 2003-12-04
ATE233239T1 (de) 2003-03-15
US5650426A (en) 1997-07-22
ES2193151T3 (es) 2003-11-01
AU5814594A (en) 1994-07-19
WO1994014772A1 (fr) 1994-07-07
JP3364222B2 (ja) 2003-01-08
MX9400035A (es) 1994-07-29
DE69332718D1 (de) 2003-04-03
DK0674621T3 (da) 2003-06-10
KR950704253A (ko) 1995-11-17
ZA939457B (en) 1995-06-19
US5618947A (en) 1997-04-08
NZ259363A (en) 1996-12-20
CA2152630C (fr) 2005-07-26

Similar Documents

Publication Publication Date Title
HK1012368A1 (en) Enantiomers of carbazole derivatives as 5-ht1-likeagonists.
GB9203347D0 (en) Hypolipidaemic compounds
MX9504349A (es) Derivados de aroilpiperidina.
MX9804107A (es) Derivados de quinolina.
AU679761B2 (en) 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands
IL123583A (en) 3-substituted -8-azabicyclo [3,2,1] oct-2-ene derivatives, their preparation and pharmaceutical compositions containing them
GR3034769T3 (en) Triazole antifungal agents.
HU9402466D0 (en) Indole derivatives as steroid-5-alpha-reductase inhibitors
GB9405492D0 (en) Chemical compounds
DE59304311D1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
AU2533492A (en) New nitrogen-containing bicyclic compounds, process for preparing them and pharmaceutical compositions containing them
CA2030732A1 (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
FI913713A0 (fi) Nya bicykliska aminosubstituerade foereningar.
HU886767D0 (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
ES8500924A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
AU639079B2 (en) N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them
IL99777A0 (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
GR3024366T3 (en) INDOLE DERIVATIVES AS STEROID 5-g(a)-REDUCTASE INHIBITORS
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
AU6703090A (en) New substituted benzothiazolinones, process for preparing these and pharmaceutical compositions containing them
ES8600204A1 (es) Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20131215